215 related articles for article (PubMed ID: 2890242)
1. Almitrine bismesylate.
Tweney J; Howard P
Z Erkr Atmungsorgane; 1987; 168(3):197-215. PubMed ID: 2890242
[TBL] [Abstract][Full Text] [Related]
2. [Almitrine bismesylate and ventilation-perfusion ratios].
Evrard Y
Rev Mal Respir; 1985; 2 Suppl 1():S17-22. PubMed ID: 2870542
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of almitrine bismesylate.
Lockhart A
Eur J Respir Dis Suppl; 1983; 126():225-31. PubMed ID: 6586437
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
5. Kidney function during arterial chemoreceptor stimulation. III. Long-lasting inhibition of renal tubular sodium reabsorption due to pharmacologic stimulation of the peripheral arterial chemoreceptors with almitrine bismesylate.
Honig A; Wedler B; Zingler C; Ledderhos C; Schmidt M
Biomed Biochim Acta; 1985; 44(11-12):1659-72. PubMed ID: 2868712
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
[TBL] [Abstract][Full Text] [Related]
7. Almitrine bismesylate: pharmacological review and structure-activity relationships.
Labrid C; Regnier G; Laubie M
Eur J Respir Dis Suppl; 1983; 126():185-9. PubMed ID: 6586432
[TBL] [Abstract][Full Text] [Related]
8. Almitrine bismesylate.
Smith PD; Gotz VP; Ryerson GG
Drug Intell Clin Pharm; 1987 May; 21(5):417-21. PubMed ID: 3556128
[TBL] [Abstract][Full Text] [Related]
9. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
[TBL] [Abstract][Full Text] [Related]
11. Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.
Stanley NN; Pieczora JA; Pauly N
Eur J Respir Dis Suppl; 1983; 126():233-7. PubMed ID: 6426992
[TBL] [Abstract][Full Text] [Related]
12. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
Nielsen SP
Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
[No Abstract] [Full Text] [Related]
13. Effects of almitrine and oxygen on ventilation and gas exchange in patients with chronic respiratory insufficiency.
Hawryłkiewicz I; Jedrzejewska-Makowska M; Górecka D; Zieliński J
Eur J Respir Dis; 1983 Oct; 64(7):512-6. PubMed ID: 6138276
[TBL] [Abstract][Full Text] [Related]
14. [Originality of the mode of action of almitrine dimesylate].
Tellier P
Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536
[TBL] [Abstract][Full Text] [Related]
15. The role of almitrine bismesylate in acute respiratory failure.
Lambropoulos S; Chatzipappas A; Tsekos G; Tsantoulis K
Eur J Respir Dis Suppl; 1986; 146():657-61. PubMed ID: 3465586
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic and pharmacokinetic interactions of almitrine bismesylate.
Campbell DB; Gordon BH; Ings RM
Rev Mal Respir; 1985; 2 Suppl 1():S39-44. PubMed ID: 2870546
[TBL] [Abstract][Full Text] [Related]
17. Effects of almitrine bismesylate 100 mg daily for four weeks on respiratory regulation in patients with chronic bronchitis.
Stanley NN
Eur J Respir Dis Suppl; 1986; 146():635-9. PubMed ID: 3096763
[TBL] [Abstract][Full Text] [Related]
18. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
[TBL] [Abstract][Full Text] [Related]
19. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
20. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo].
Paramelle B; Joubert C; Dain MP
Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
